BROOKE RICHARD: Open Payments
NPI 1669841938 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 18 payments from 11 companies in 2025. Trend: 2023 $450 · 2024 $593 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| SI-BONE, INC. | 1 | $123 |
| KYOCERA MEDICAL TECHNOLOGIES, INC. | 1 | $117 |
| ABBVIE INC. | 4 | $73 |
| Biogen, Inc. | 3 | $68 |
| Neurelis, Inc. | 2 | $55 |
| UCB, Inc. | 2 | $52 |
| Merz Pharmaceuticals, LLC | 1 | $29 |
| Globus Medical, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: UBRELVY, LEQEMBI, VALTOCO, Xeomin, Fintepla, Nayzilam, EXCELSIUS GPS, REXULTI.
Industry payments across LA — which companies pay providers there.
